D-0055-2018 Class II Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-0055-2018 was initiated by AVKARE Inc. on Oct 6, 2017 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid. The recall status is terminated (terminated Mar 11, 2019). Affected quantity: 274 cartons.

Recall details

Product Type
Drugs
Report Date
Nov 8, 2017
Initiation Date
Oct 6, 2017
Termination Date
Mar 11, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
274 cartons

Product description

Duloxetine Delayed-release Capsules USP, 20 mg, 50 Capsules (5 x 10) Unit Dose per carton, unit dose blister UPC 5026828311), Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-283-15.

Reason for recall

Failed Impurities/Degradation Specifications: slightly elevated levels of phthalic acid.

Distribution pattern

Nationwide in the USA

Code information

Lot: 18103 Exp. 11/18

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0055-2018
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0055-2018. Report a data issue: hello@regdatalab.com.